Prospective comparison of hormone withdrawal symptoms of a 24/4 regimen with a 21/7 regimen of OC.

Trial Profile

Prospective comparison of hormone withdrawal symptoms of a 24/4 regimen with a 21/7 regimen of OC.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2010

At a glance

  • Drugs Ethinylestradiol/norethisterone (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Apr 2008 Status changed from recruiting to in progress, reported by ClinicalTrials.gov.
    • 30 Jul 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top